Addex Therapeutics
web2Addex Therapeutics is a Swiss clinical stage biopharmaceutical company developing small molecul...
About
Addex Therapeutics is a Swiss clinical stage biopharmaceutical company developing small molecule medicines that modify neurological signaling pathways to investigate treatments for central nervous system disorders. Its research focuses on allosteric modulators, compounds that influence receptor activity by binding at sites distinct from the receptor's principal signaling site. Development programs include candidates targeting GABAB receptors for chronic cough and substance use disorders, alongside other neurological applications. The company also has interests in Neurosterix, a separately developed drug discovery business. Addex conducts pharmaceutical research and clinical development rather than operating as a commercial supplier of approved medicines.
Explore this sector
Exchange listings
Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.
Addex Therapeutics profile.
Expert coverage
No published expert evaluations are available for this project yet.
Orbitrum Academy